Skip to content
Review Open access

Towards precision medicine in valvular heart diseases: a systematic review of predictive multimodal machine learning models

Oct 2026 · European Heart Journal · 0 citations

TL;DR

While multimodal models offer notable performance advantages over unimodal approaches, their application in VHD remains limited and future research should prioritize the integration of heterogeneous data sources alongside rigorous external validation to ensure clinical generalizability and facilitate adoption in valvular care.

Abstract

Machine learning (ML) can facilitate the integration of vast disparate clinical data for precise clinical care. This is especially crucial in areas such as the diagnosis and management of valvular heart diseases (VHDs), where clinical decision-making is inherently reliant on the synthesis of multiple data sources. To systematically review studies of predictive machine learning models for VHDs, focusing on the use and prevalence of multimodal models. We conducted a systematic review adhering to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. PubMed, Web of Science, and Embase were searched between 2014 and 2025. Eligible peer-reviewed studies that developed predictive ML models for VHDs were included. Titles and abstracts were screened independently by two reviewers, with a third reviewer consulted to resolve any conflicts. Information on the primary predictive task, data modality, model architecture and performance were extracted. Risk of bias was independently assessed by two reviewers using the PROBAST+AI tool. A total of 195 studies were included in the review. Left-sided lesions, most notably aortic stenosis, predominated, representing 97% of single-disease models and the majority of cases in multi-disease analyses. Diagnostic prediction models accounted for 62% of the studies, while 38% focused on prognostic prediction. Only 8% of the included studies developed multimodal models. Among those comparing multimodal and unimodal approaches, multimodal models demonstrated an average performance gain of 6.3%. This improvement was more pronounced when integrating structured data with unstructured sources (8.0%) compared to combining unstructured modalities alone (4.0%). The largest increases in performance were observed with mitral regurgitation (MR) diagnosis when tabular clinical data were combined with ECG (+22%) and heart sound recordings (+11%). However, despite these performance gains, only 31% of the multimodal models underwent external validation. Additionally, a subset of studies was identified as 'unimodal with multisource learning', where handcrafted variables from heterogeneous sources were consolidated into a single structured input. ML is increasingly used for the diagnosis and management of VHDs. While multimodal models offer notable performance advantages over unimodal approaches, their application in VHD remains limited. Future research should prioritize the integration of heterogeneous data sources alongside rigorous external validation to ensure clinical generalizability and facilitate adoption in valvular care.Figure 1Figure 2

Read PDF

Similar papers

Review Open access Oct 2026

Predictive performance of machine learning models for bloodstream infection by validation type: A systematic review and meta-analysis.

A systematic review and meta-analysis of ML-based BSI prediction models to quantify their discriminative performance and appraise the certainty of the evidence concluded that Rigorous external validation, calibration and decision-analytic reporting, and adherence to prediction-model reporting standards are needed befor...

Heejeong Kwon, Jaewoong Kim, Hyunok Yun et al. · 0 citations
Review Open access Oct 2026

Performance of machine learning models for CKD progression and kidney failure: a systematic review

Machine learning (ML) is increasingly applied to predicting chronic kidney disease (CKD) progression and kidney failure using routinely collected healthcare data, but the methodological quality and clinical applicability of these models remain uncertain. We hypothesised that ML models would show strong discrimina...

Louise Aubiniere-Robb, Joshua Tandy, B. Jani et al. · 0 citations
Review Open access Oct 2026

Machine learning and deep learning for predicting acute exacerbation in chronic obstructive pulmonary disease: a systematic review

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) imposes a substantial burden on patients and healthcare systems. Although traditional risk assessment tools exist, machine learning (ML) and deep learning (DL) may offer improved prediction. This systematic review aims to evaluate the performanc...

Qiong-Hua Xiao, Hui-Ru Li, Jiang Yang et al. · 0 citations
Review Open access Sep 2026

A systematic review on cardiovascular risk stratification in the artificial intelligence paradigm using radiogenomics

Background: The cardiovascular risk and patient management are evaluated on the basis of risk scores that account for the multifactorial risk factors and thus fail in the estimation of an individual’s cardiovascular disease (CVD) risk. Advances in the field of medical imaging, especially cardiac computed tomography ang...

Manasvi Singh, N. Khanna, A. Nicolaides et al. · 0 citations
Review Open access Sep 2026

Machine learning models for identifying prediabetes: a systematic review of performance, validation, and implications for primary care

Background Machine learning models have been proposed for identifying prediabetes, but their methodological quality, generalisability, and readiness for primary care implementation remain uncertain. Methods We conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020-compliant systema...

Liang Wang, Yan Zhang, Hao Yang et al. · 0 citations
Review Open access Sep 2026

Diagnostic Accuracy of Machine Learning-Enhanced Methods for Pulmonary Hypertension: A Systematic Review and Meta-Analysis

Background/Objectives: Right heart catheterization (RHC) is the diagnostic gold standard for pulmonary hypertension (PH), defined as mean pulmonary arterial pressure (mPAP) greater than 20 mmHg at rest. It is invasive and carries procedural risk. Machine learning (ML) and deep learning (DL) applied to non-invasive moda...

Faizan Ahmed, A. Zulfiqar, T. Bhadra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.